The crystal structure of multidrug-resistance regulator RamR with multiple drugs

被引:79
|
作者
Yamasaki, Suguru [1 ,2 ]
Nikaido, Eiji [1 ,2 ]
Nakashima, Ryosuke [3 ]
Sakurai, Keisuke [3 ]
Fujiwara, Daisuke [4 ]
Fujii, Ikuo [4 ]
Nishino, Kunihiko [1 ]
机构
[1] Osaka Univ, Inst Sci & Ind Res, Div Special Projects, Lab Microbiol & Infect Dis, Ibaraki, Osaka 5670047, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Inst Sci & Ind Res, Div Special Projects, Lab Cell Membrane Struct Biol, Ibaraki, Osaka 5670047, Japan
[4] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998531, Japan
来源
NATURE COMMUNICATIONS | 2013年 / 4卷
关键词
ENTERICA SEROVAR TYPHIMURIUM; EFFLUX PUMPS; SALMONELLA-TYPHIMURIUM; KLEBSIELLA-PNEUMONIAE; TETR FAMILY; EXPRESSION; BACTERIA; MUTATIONS; ACRAB; SUSCEPTIBILITY;
D O I
10.1038/ncomms3078
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
RamR is a transcriptional repressor of the gene-encoding RamA protein, which controls the expression of the multidrug efflux system genes acrAB-tolC. RamR is an important multidrug-resistance factor, however, its structure and the identity of the molecules to which it responds have been unknown. Here we report the crystal structure of RamR in complex with multiple drugs, including berberine, crystal violet, dequalinium, ethidium bromide and rhodamine 6G. All compounds are found to interact with Phe155 of RamR, and each compound is surrounded by different amino acid residues. Binding of these compounds to RamR reduces its DNA-binding affinity, which results in the increased expression of ramA. Our results reveal significant flexibility in the substrate-recognition region of RamR, which regulates the bacterial efflux participating in multidrug resistance.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] CARBOXYLESTERASES AND THE REVERSAL OF THE MULTIDRUG-RESISTANCE
    MARKOVIC, OT
    MARKOVIC, NS
    MARKOVIC, SN
    CLINICAL RESEARCH, 1994, 42 (02): : A127 - A127
  • [22] IS THE MULTIDRUG-RESISTANCE AN ATP CHANNEL
    ARIAS, IM
    HEPATOLOGY, 1993, 18 (01) : 216 - 217
  • [23] MULTIDRUG-RESISTANCE IN MALIGNANCIES OF CHILDREN
    CHAN, HSL
    THORNER, PS
    HADDAD, G
    DEBOER, G
    GALLIE, BL
    LING, V
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1995, 2 (01): : 11 - 29
  • [24] MULTIDRUG-RESISTANCE IN PEDIATRIC MALIGNANCIES
    CHAN, HSL
    DEBOER, G
    HADDAD, G
    GALLIE, BL
    LING, V
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (02) : 275 - 318
  • [25] ARE ESTERASES INVOLVED IN MULTIDRUG-RESISTANCE
    MARKOVIC, O
    MARKOVIC, N
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (20) : 1693 - 1693
  • [26] PHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE
    FORD, JM
    HAIT, WN
    CYTOTECHNOLOGY, 1993, 12 (1-3) : 171 - 212
  • [27] Immunosuppressors and reversion of multidrug-resistance
    Aouali, N
    Eddabra, L
    Macadré, J
    Morjani, H
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (01) : 61 - 70
  • [28] MULTIDRUG-RESISTANCE IN HUMAN CANCER
    GOTTESMAN, MM
    GOLDSTEIN, LJ
    GALSKI, H
    PASTAN, I
    BREAST CANCER : PROGRESS IN BIOLOGY, CLINICAL MANAGEMENT AND PREVENTION, 1989, 58 : 117 - 123
  • [29] MULTIDRUG-RESISTANCE IN THE LABORATORY AND CLINIC
    BELLAMY, WT
    DALTON, WS
    ADVANCES IN CLINICAL CHEMISTRY, VOL 31, 1994, 31 : 1 - 61
  • [30] MODULATION OF MULTIDRUG-RESISTANCE - AT THE THRESHOLD
    SIKIC, BI
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) : 1629 - 1635